# 3 Days Versus 5 Days Amoxicillin for Chest-indrawing Childhood Pneumonia in Malawi

> **NCT02678195** · PHASE4 · COMPLETED · sponsor: **Save the Children** · enrollment: 3000 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Amoxicillin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02678195
- **Lead sponsor:** Save the Children
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2019-04
- **Final completion:** 2019-12
- **Target enrollment:** 3000 (ACTUAL)
- **Last updated:** 2021-02-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02678195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02678195, "3 Days Versus 5 Days Amoxicillin for Chest-indrawing Childhood Pneumonia in Malawi". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02678195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*